Home
overview

As a pharmaceutical/healthcare professional, you know how valuable KOLs are to your organisation and how they contribute to the success of your clinical research. In today's competitive and challenging market, it is vital that relationship between the pharmaceutical/healthcare industry and KOLs are not only built but nurtured and maintained.

Identifying and engaging KOLs for your organisation is crucial to the success of your product. Entering European markets is a challenge faced by the pharmaceutical industry with ever-changing pricing structures and regulations. Working closely and adopting a culture of transparent collaboration and engagement with KOLs helps overcome some of these challenges.

SMi is proud to present KOL Knowledge Leaders focussed to keep our audience up-to-date with developments in the ever-changing KOL sphere.
 

 

Hear about all the latest regulatory guidance in the European markets
Identify and engage with KOL through effective social media and traditional channels
Gain an insight into current transparent and flexible relationships
Improve your relationship with key leaders
Overcome cultural barriers and dealing with change management
Establish the return on investment for your KOL and MSL management
Develop a successful KOL management program
 

• Medical Science Liaisons, MSLs
• Medical Affairs, Scientific Affairs
• Medical Advisors, Scientific Advisors
• KOL Development, KOL Relationships
• Key Opinion Management
• External Speaker Faculty Management
• Medical Communications
• Clinical Outcomes
• Scientific Affairs
• Medical Education
• External Stakeholder Management/Liaison
• Programme/Product/Brand Management
• Marketing
• Professional Education
 

• Shire
• Pfizer
• Grunenthal
• Boehringer Ingelheim
• Nycomed
• Innogenetics
• European Parkinsons Disease Association
• Merck
• Leo Pharma
• Eli Lilly
• AstraZeneca
• Association of the British Pharmaceutical Industry
• Genzyme
• Kings College, London
• Bristol-Myers Squibb
• UCB Gmbh
• Novartis
• Bayer Schering Pharma
• MedImmune
• Amgen
• Harvard Medical School
• GSK
• Sanofi-Aventis
• Abbott
• Napp Pharmacueticals
• Mederi
• Caudex Medical
• Tachris AG
• Celgene International
• Biogen Idec International
• University College London
• British Medical Journal
• Norgine
• Vifor Pharma
 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Wisia Wedzicha

Wisia Wedzicha, Professor of Respiratory Medicine, University College London

David Gillen

David Gillen, Medical Director , Celgene Europe Limited

9:10 KOL for pharmaceuticals: defining the landscape

Wisia Wedzicha

Wisia Wedzicha, Professor of Respiratory Medicine, University College London

  • What is the nature of the role of a KOL in the development process?
  • How will we define and recognise a KOL?
  • Objective-driven approach to initiate partnership with the pharmaceutical industry
  • Ensuring the right KOL is identified for the right project
  • 9:50 Ensuring regulatory compliance with key external expert data

    Mario Monella

    Mario Monella, Director of Medical Affairs, Astellas Pharma Europe Ltd

  • Industry trends in KEE database management
  • Common issues and uncertainties related to privacy
  • Structure and strategies for ensuring global compliance
  • 10:30 Morning Coffee

    10:50 Key elements of a Stakeholder Relations

    Johanna Jarvis

    Johanna Jarvis, Managing Director , Jarvis Consulting

  • Stepwise approach to stakeholder relations business planning
  • Standardising stakeholder engagement planning
  • 11:30 The evolving role of the KOL in the pharmaceutical industry

    Christian Felter

    Christian Felter, Associate Director, Medical Affairs, Astellas Pharma Europe

  • Understanding the role of the KOL for your organisation
  • How does the role differ through the late research and early development phase
  • In what direction is the area evolving?
  • Collating and interpreting feedback from criticisms; learning from past mistakes
  • 12:10 Global health agenda: overcoming the challenges

    Mario Ottiglio

    Mario Ottiglio, Associate Director Public Affairs & Global Health Policy , IFPMA

  • Understanding what the top priorities are for the global health agenda
  • Identifying what our industry is expected to deliver
  • Overcoming challenges
  • Looking to the future
  • 12:50 Networking Lunch

    14:00 The internet, social media and mobile

    Daniel Ghinn

    Daniel Ghinn, Director of Digital Engagement, Healthcare, Creation Interactive

  • How emerging channels are changing healthcare engagement
  • Focus on how pharma's stakeholder communicate
  • Influencing other KOLs using emerging channels
  • What does this mean for the pharma industry?
  • 14:40 Evolution of MSL role in different European markets

    David Gillen

    David Gillen, Medical Director , Celgene Europe Limited

  • Assessing the changing roles of MSLs
  • Dealing with patient expirations and mergers and acquisitions in the industry
  • Getting top-level management buy-in for MSLs
  • Building depper relationships in the European market
  • 15:20 Afternoon Tea

    15:40 The implications of the Bribery Act 2010 for pharmaceutical/healthcare companies’ relationships with KOLs

    Shaul Brazil

    Shaul Brazil , Barrister, BCL Burton Copeland

  • Overview of the main aspects of the Bribery Act
  • The relevance of the Bribery Act to KOL relationships
  • The practical implications for KOL relationships
  • Effective procedures for ensuring compliance
  • 16:20 Stakeholder Relations: What is it? What is the value?

  • Stakeholder Relations Environmental changes and challenges
  • Standardising Stakeholder Relations business and engagement planning
  • Effective interaction with key stakeholder groups
  • Joint presentation with a key Stakeholder on effective interaction
  • Johanna Jarvis

    Johanna Jarvis, Managing Director , Jarvis Consulting

    Tim Curry

    Tim Curry, Assistant Head of Nursing , Royal College Of Nursing Of The United Kingdom

    17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Keith Allan

    Keith Allan, Director of Global Advocacy, Novartis International AG

    9:10 Adopting a culture of transparent engagement and collaborations with pharmaceuticals

    Neil Ranasinghe

    Neil Ranasinghe, Medical Sciences Manager, BMS

  • Why transparency regarding KOL/pharma  interactions benefits everyone involved
  • What can KOLs offer healthcare professionals
  • What can healthcare professionals offer the industry when interacting with MSLs
  • How an MSL/KOL guidance can help all involved
  • 9:50 Assessing the impact of current legislation on relationships between pharmaceutical companies and KOLs’

    Audrey  Craven

    Audrey Craven, President , European Federation of Neurological Associations (EFNA)

     

  • Partnerships for progress
  • Sharing best practice
  • Building capacity
  • Influencing policy makers
  • 10:30 Morning Coffee

    10:50 Measuring the success of your KOL program

    Sanjita  Panchal

    Sanjita Panchal, Medical Science Liaison, Merck Sharp & Dohme Ltd

  • Measuring internal success: identifying and engaging with your KOL
  • Demonstrating the success to management
  • Predicting future success
  • 11:30 Understanding German legislation and increased regulatory enforcement

    Alexander Natz

    Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Eucope)

  • Familiarising yourself with European and German legislation
  • The need for improved transparent information and the new information to patients proposal of the European Commission
  • Codes of conduct, patient and KOL involvement
  • Pharmacovigilance and restrictions of advertisement laws
  • Creating a compliance team within your organisation to suit the European markets
  • 12:10 Networking Lunch

    13:30 Getting the relationship right: Interaction between KOL and the pharmaceutical industry

    Keith Allan

    Keith Allan, Director of Global Advocacy, Novartis International AG

  • Reviewing the state of the relationship between pharma and the medical research community
  • Evolving new approaches to working together for the benefit of medicine
  • Ensuring a flexible and customised program that fits the unique needs of each key opinion leader
  • Identifying where the challenge currently lies in the relationship and rectifying this through effective management

     

  • 14:10 Engaging with Patient Opinion Leaders (POLs)

    Susanna Palkonen

    Susanna Palkonen, Executive Officer, EFA

  • New legislation and how this will effect KOL relations
  • Will Patient Opinion Leaders (POLs) replace KOLs
  • How to get these groups on board
  • How do patient organisations feel about engaging
  • 15:20 The changing profiles of KOL

    Miriam  George

    Miriam George, CEO, PDC Healthcare

  • New environment, new opportunities
  • Providing more than just a drug
  • Demonstrating value
  • 16:00 Afternoon Tea

    16:30 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Alexander Natz

    Alexander Natz

    Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Eucope)
    Audrey  Craven

    Audrey Craven

    President , European Federation of Neurological Associations (EFNA)

    Alexander Natz

    Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Eucope)
    Alexander Natz

    Audrey Craven

    President , European Federation of Neurological Associations (EFNA)
    Audrey  Craven

    Christian Felter

    Associate Director, Medical Affairs, Astellas Pharma Europe
    Christian Felter

    Daniel Ghinn

    Director of Digital Engagement, Healthcare, Creation Interactive
    Daniel Ghinn

    David Gillen

    Medical Director , Celgene Europe Limited
    David Gillen

    Johanna Jarvis

    Managing Director , Jarvis Consulting
    Johanna Jarvis

    Keith Allan

    Director of Global Advocacy, Novartis International AG
    Keith Allan

    Mario Monella

    Director of Medical Affairs, Astellas Pharma Europe Ltd
    Mario Monella

    Mario Ottiglio

    Associate Director Public Affairs & Global Health Policy , IFPMA
    Mario Ottiglio

    Michal Konstacky

    Aerocrine, Head of Medical Affairs
    Michal Konstacky

    Miriam George

    CEO, PDC Healthcare
    Miriam  George

    Neil Ranasinghe

    Medical Sciences Manager, BMS
    Neil Ranasinghe

    Sanjita Panchal

    Medical Science Liaison, Merck Sharp & Dohme Ltd
    Sanjita  Panchal

    Shaul Brazil

    Barrister, BCL Burton Copeland
    Shaul Brazil

    Susanna Palkonen

    Executive Officer, EFA
    Susanna Palkonen

    Tim Curry

    Assistant Head of Nursing , Royal College Of Nursing Of The United Kingdom
    Tim Curry

    Wisia Wedzicha

    Professor of Respiratory Medicine, University College London
    Wisia Wedzicha

    VENUE

    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.